Cite
HARVARD Citation
Morano, F. et al. (2022). Temozolomide Followed by Combination With Low-Dose Ipilimumab and Nivolumab in Patients With Microsatellite-Stable, O6-Methylguanine–DNA Methyltransferase–Silenced Metastatic Colorectal Cancer: The MAYA Trial. Journal of clinical oncology. 40 (14), pp. 1562-1573. [Online].